This study provides new information that early vitamin A treatment might help lower overall Ebola virus disease mortality. Because vitamin A has well-established immunological impacts in infectious disease states, the researchers hypothesized it could have clinical benefits among those with Ebola virus disease. The study team, led by Adam Levine (Brown University Warren Alpert Medical School) and colleagues, evaluated the impact of early vitamin A supplementation on mortality among patients with Ebola virus disease admitted to 5 International Medical Corps Ebola Treatment Units in 2 West African countries.
Ebola virus disease: Can vitamin A supplementation lower overall mortality?
This study led by Adam Levine provides new information that early vitamin A treatment might help lower overall Ebola virus disease mortality.